PTCT Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - PTC Therapeutics Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 33.66 USD 7.95%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast PTCT stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PTCT is 28.84 USD with a low forecast of 16.16 USD and a high forecast of 47.25 USD.

PTCT Lowest Forecast

Wall Street Target

PTCT Average Forecast

Wall Street Target

PTCT Highest Forecast

Wall Street Target

52% Downside

14% Downside

40% Upside

The latest public price target was made on Apr 26, 2024 by Jeffrey Hung from Morgan Stanley , who expects PTCT stock to drop by 11% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst	Price Target	Date	Article
Jeffrey Hung Morgan Stanley	30 USD Downside 11%	2 weeks ago Apr 26, 2024	Morgan Stanley Upgrades PTC Therapeutics (PTCT) to Equalweight StreetInsider

Price Target	30 USD
Upside/Downside	11%

CytomX Therapeutics Inc

108% Upside

XOMA Corp

135% Upside

Apogee Therapeutics Inc

64% Upside

Caribou Biosciences Inc

460% Upside

CytomX Therapeutics Inc

108% Upside

XOMA Corp

135% Upside

Apogee Therapeutics Inc

64% Upside

Caribou Biosciences Inc

460% Upside

Mineralys Therapeutics Inc

164% Upside

Pacific Shuanglin Bio pharmacy Co Ltd

5% Downside

Halozyme Therapeutics Inc

14% Upside

Niox Group PLC

8% Upside

Revenue
Forecast

For the last 8 years the compound annual growth rate for PTC Therapeutics Inc's revenue is 50%. The projected CAGR for the next 3 years is -6%.

50%

-6%

-2%

What are analyst estimates?

Operating Income
Forecast

N/A

N/A

4%

What are analyst estimates?

Net Income
Forecast

N/A

N/A

-14%

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for PTCT is 28.84 USD with a low forecast of 16.16 USD and a high forecast of 47.25 USD.

For the last 8 years the compound annual growth rate for PTC Therapeutics Inc's revenue is 50%. The projected CAGR for the next 3 years is -6%.

Join more than 137,600+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.